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Abstract. 
 
Members of the protein kinase C (PKC)
family of signal transduction molecules have been
widely implicated in regulation of cell growth and dif-
ferentiation, although the underlying molecular mech-
anisms involved remain poorly deﬁned. Using com-
bined in vitro and in vivo intestinal epithelial model
systems, we demonstrate that PKC signaling can trigger
a coordinated program of molecular events leading to
 
cell cycle withdrawal into G
 
0
 
. PKC activation in the
IEC-18 intestinal crypt cell line resulted in rapid down-
regulation of D-type cyclins and differential induction
of p21
 
waf1/cip1
 
 and p27
 
kip1
 
, thus targeting all of the major
G
 
1
 
/S cyclin-dependent kinase complexes. These events
were associated with coordinated alterations in expres-
sion and phosphorylation of the pocket proteins p107,
pRb, and p130 that drive cells to exit the cell cycle into
G
 
0
 
 as indicated by concomitant downregulation of the
DNA licensing factor cdc6. Manipulation of PKC
 
isozyme levels in IEC-18 cells demonstrated that PKC
 
a
 
alone can trigger hallmark events of cell cycle with-
drawal in intestinal epithelial cells. Notably, analysis of
the developmental control of cell cycle regulatory mol-
ecules along the crypt–villus axis revealed that PKC
 
a
 
activation is appropriately positioned within intestinal
crypts to trigger this program of cell cycle exit–speciﬁc
events in situ. Together, these data point to PKC
 
a
 
 as a
key regulator of cell cycle withdrawal in the intestinal
epithelium.
Key words: protein kinase C • cell cycle • intestinal
mucosa • pocket proteins • cyclin-dependent kinase
regulation
 
Introduction
 
Signaling pathways mediated by the protein kinase C
 
(PKC)
 
1
 
 family of serine-threonine kinases are involved in
the regulation of a wide variety of fundamental cellular
processes, including cell growth and cell cycle progression,
differentiation, and apoptosis (Nishizuka, 1992; Dekker
and Parker, 1994; Fishman et al., 1998; Black, 2000). The
 
PKC family consists of at least 10 distinct isozymes (
 
a
 
, 
 
bI
 
,
 
bII
 
, 
 
g
 
, 
 
d
 
, 
 
e
 
, 
 
h
 
, 
 
u
 
, 
 
z
 
, and 
 
i
 
) which share the same basic struc-
ture but differ with respect to activator and cofactor re-
quirements, substrate specificity, tissue expression, and
subcellular distribution (Dekker and Parker, 1994). Phylo-
genetic conservation of individual PKCs and their wide-
spread expression in different cell types underscore the
central importance of members of this family in regulation
of normal cellular functions. Furthermore, evidence of al-
terations in the expression/activity of PKC isozymes in
neoplastic tissues (e.g., Guillem et al., 1987; Wali et al.,
1991; Kahl-Rainer et al., 1996; Verstovsek et al., 1998), to-
gether with the identification of PKC as the major cellular
receptor for tumor-promoting phorbol esters (e.g., PMA)
(Castagna et al., 1982), suggests that disruption of the sig-
naling pathways mediated by these molecules may contrib-
ute to uncontrolled cell growth and transformation.
Increasing evidence points to a role for PKC signaling in
regulation of progression through the cell cycle, although
the underlying molecular mechanisms remain unclear
 
(Fishman et al., 1998; Black, 2000). Control of G
 
0
 
/G
 
1
 
®
 
S
phase transit is accomplished primarily through regulation
of the phosphorylation state of members of the pocket pro-
tein family of growth suppressor proteins, p107, pRb, and
p130. In the hypophosphorylated (active) state, these mole-
cules repress the activity of E2F transcription factors, which
is required for expression of genes essential for DNA syn-
 
thesis. In preparation for S phase entry, cyclin–cyclin-
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dependent kinase (cdk) complexes (cyclin D–cdk4/6 and
cyclin E–cdk2) phosphorylate pRb, p107, and p130, inac-
tivating their growth-suppressive function (Graña and
Reddy, 1995). An additional complex, cyclin A–cdk2, is crit-
ical for S phase entry/DNA synthesis, and is thought to
maintain pocket protein phosphorylation during S phase
(Li et al., 1993; Ludlow et al., 1993; Mayol et al., 1995). The
activity of cyclin–cdk complexes is in turn regulated by
cdk phosphorylation, expression and binding of cyclins,
and association of cdk inhibitory proteins (CKIs) such as
p21
 
waf1/cip1
 
 and p27
 
kip1
 
 (Cip/Kip family members) and p15
and p16 (Ink4 family members) (Pines, 1995; Chellappan et
al., 1998; Sherr and Roberts, 1999). Pocket protein function
has also been linked to regulation of cell cycle exit and on-
set of differentiation; cell cycle withdrawal into G
 
0
 
 involves
coordinated regulation of pocket protein phosphorylation
and expression, including hypophosphorylation of p107 and
pRb, rapid downregulation of p107, and accumulation of
the G
 
0
 
-specific phosphoforms 1 and 2 of p130 (Garriga et
al., 1998; Graña et al., 1998). Emerging data from several
studies implicate PKC isozyme(s) in either positive or nega-
tive regulation of G
 
1
 
®
 
S progression, via alterations in the
expression of cyclins and/or cdk inhibitors and modulation
of the activity of specific cyclin–cdk complexes (Fishman et
al., 1998; Black, 2000).
In an effort to further understand the interplay be-
tween PKC signaling and regulation of the cell cycle ma-
chinery, our laboratory has used the intestinal epithelium
as a model system. The unique architecture of this self-
renewing tissue, with its well-defined regions of cell
proliferation, differentiation, mature function, and senes-
cence, has enabled correlation of changes in the expres-
sion and activation of PKC isozymes with specific stages
of development. Using a combined morphological and
biochemical approach, we have determined that several
PKC isozymes (
 
a
 
, 
 
bII
 
, 
 
d
 
, and 
 
z
 
) are activated precisely at
the point within intestinal crypts at which cells cease di-
viding (Saxon et al., 1994), suggesting that one or more of
these molecules are involved in negative regulation of
cell growth in this system. Consistent with these findings,
direct activation of PKC (
 
a
 
, 
 
d
 
, and 
 
e
 
) in the nontrans-
formed IEC-18 immature intestinal crypt cell line re-
sulted in cell cycle arrest in G
 
0
 
/G
 
1
 
 phase (Frey et al.,
1997). Differential downmodulation of individual PKC
isozymes indicated that PKC
 
a
 
, in particular, is sufficient
to inhibit cell cycle progression in this system. PKC-
mediated cell cycle arrest in G
 
0
 
/G
 
1
 
 was shown to involve
induction of Cip/Kip family cdk inhibitors and hypophos-
phorylation/activation of pRb, thus linking PKC
 
a
 
 to
control of cdk activity and the growth-suppressive func-
tion of pRb in the intestinal epithelium.
This study uses in vitro and in vivo model systems to in-
vestigate further the cell cycle–specific effects of PKC sig-
naling in intestinal epithelial cells. The data demonstrate
for the first time that PKC signaling can initiate a coordi-
nated program of cell cycle withdrawal into G
 
0
 
 and that
PKC
 
a
 
 is sufficient to initiate this program of cell cycle
exit–specific effects. Similar changes in the regulation of
cell cycle regulatory molecules were observed coincident
with PKC activation in the midcrypt region in situ, under-
scoring the physiological relevance of these findings. To-
gether, the data implicate members of the PKC family as
key regulators of cell cycle withdrawal in the midcrypt re-
gion of the intestinal epithelium. 
 
Materials and Methods
 
Antibodies
 
Monoclonal anti–cyclin D1, polyclonal rabbit anti-p15, -p16, -cdk4, –cyclin
A, –cyclin D (pan), –cyclin E, -pRb, -p107, -p130, -PKC
 
d
 
, and -PKC
 
e
 
, and
polyclonal goat anti-p15 and -cdk2 antibodies were obtained from Santa
Cruz Biotechnology, Inc. Monoclonal against 5
 
9
 
-bromo-2
 
9
 
-deoxyuridine
(BrdU) was purchased from Dako. mAbs recognizing p21
 
waf1/cip1
 
 and pRb
were purchased from BD PharMingen, mABs anti-p27
 
kip1
 
 was obtained
from BD Transduction Labs, and monoclonal anti–cyclin D1 was pur-
chased from Sigma-Aldrich. Polyclonal and monoclonal PKC
 
a
 
-specific
antibodies were purchased from GIBCO BRL and Upstate Biotechnol-
ogy, respectively. HRP-conjugated goat anti–rabbit IgG and donkey anti–
goat IgG antibodies, and unconjugated anti–green fluorescent protein
(GFP) mAb were obtained from Boehringer. HRP-conjugated rat anti–
mouse IgG, TRITC-conjugated donkey anti–rabbit IgG, and TRITC-con-
jugated goat anti–mouse IgG antibodies were purchased from Jackson
ImmunoResearch Laboratories. TRITC-conjugated donkey anti–goat
IgG and unconjugated goat anti–mouse IgG were obtained from Accurate
Chemical & Scientific Corp.
 
Identification of Proliferating Crypt Cells In Situ
 
To label proliferating intestinal epithelial cells in S phase, an aqueous so-
lution of 120 mg/kg of the thymidine analogue BrdU (Sigma-Aldrich) was
injected intraperitoneally into Sprague-Dawley (CD) rats (Charles River
Laboratories) 2 h before killing. Paraffin sections of formalin-fixed duode-
num were heated (95
 
8
 
C) in 10 mM citrate buffer, pH 6.0, for 20 min for
antigen retrieval, blocked in PBS containing 0.03% casein and 0.05%
Tween 20, and immunostained with anti-BrdU antibody (1:10 dilution),
followed by unconjugated goat anti–mouse secondary antibody (1:100 di-
lution) and HRP-conjugated donkey anti–goat tertiary antibody (1:100 di-
lution). Bound peroxidase was detected by incubation in 0.1% diami-
nobenzidine and 0.01% H
 
2
 
O
 
2
 
, and sections were counterstained with
Harris hematoxylin.
 
Immunofluorescence Staining
 
Duodenal tissue from 200-g male Sprague-Dawley (CD) rats (Charles
River Laboratories) was removed and flushed with ice-cold PBS. Tissue
used for p15, p16, cyclin D1, and cdk2 immunostaining was immediately
frozen in liquid nitrogen–cooled 2-methylbutane. Sections (4–6 
 
m
 
m) were
cut on a cryostat microtome (Reichert-Jung), thaw-mounted onto gelatin-
coated coverslips, and fixed in 2% formaldehyde/PBS for 15 min. Tissue
used for p21
 
waf1/cip1
 
, p27
 
kip1
 
, cdk4, cyclin A, cyclin E, p107, pRb, p130, and
PKC
 
a
 
 immunostaining was fixed immediately after removal in 2% freshly
depolymerized paraformaldehyde/PBS for 2 h at 4
 
8
 
C, washed three times
(15 min) in 50 mM NH
 
4
 
Cl/PBS, cryoprotected in 30% sucrose/PBS for at
least 5 h, and frozen as described above.
Nonspecific binding of antibodies to tissue sections was blocked by pre-
incubation in blocking buffer (PBS containing 0.03% casein and 0.05%
Tween 20) for 30 min at room temperature. Sections were then immuno-
stained essentially as described previously (Saxon et al., 1994). In brief,
sections were incubated with primary antibody in PBS containing 0.2%
Triton X-100 (Sigma-Aldrich) for 60 min, followed by a 15-min PBS/Tri-
ton wash, 40 min in secondary antibody in PBS/Triton, and a 15-min PBS
wash. Primary antibody dilutions were 1:10 for anti–cyclin D1, 1:25 for
anti-cdk2 and -p21
 
waf1/cip1
 
, 1:50 for anti-p27
 
kip1
 
, 1:100 for anti-PKC
 
a
 
, -p16,
–cyclin A, –cyclin E, and -p130, 1:200 for anti-cdk4, -p107, and -pRb, and
1:400 for anti-p15. TRITC-conjugated secondary antibodies were used at
1:100 dilution. Fluorescence was viewed with a ZEISS epifluorescence mi-
croscope equipped with the appropriate optics and filter modules.
 
Cell Culture, PKC Activation Protocols, and 
Subcellular Fractionation
 
The IEC-18 cell line (American Type Culture Collection), a nontransformed
intestinal crypt cell line derived from rat ileal epithelium (Quaroni and May,
1980), was maintained in DME (GIBCO BRL) supplemented with 10 
 
m
 
g/ml
insulin, 4 mM glutamine, and 5% FCS (Intergen). PKC isozymes were acti-
vated in these cells by treatment with a panel of PKC activators including 100
nM PMA (Sigma-Aldrich), 100 nM 12-deoxyphorbol 13-phenylacetate (dPP;
Alexis Corp.), 58 
 
m
 
M 1,2-dioctanoyl-
 
sn
 
-glycerol (DiC
 
8
 
; Sigma-Aldrich), 100
nM phorbol 12,13-dibutyrate (PDBu; Alexis Corp.), 200 nM 12-deoxyphor-
bol 13-phenylacetate 20-acetate (dPPA; Alexis Corp.), 20 nM thymeleatoxin
(Thy; Alexis Corp.), or 10 
 
m
 
M resiniferatoxin (Res; Alexis Corp.).  
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Construction of a Retroviral Vector for Expression of 
PKC
 
a
 
-GFP Fusion Protein in IEC-18 Cells
 
To generate a retroviral vector for expression of PKC
 
a
 
 fused at its COOH
terminus to the NH
 
2
 
-terminal end of GFP, PKC
 
a
 
 cDNA (American Type
Culture Collection) was excised from pBluescript with EcoR1 and ligated
into the EcoR1 sites of EGFP-N1 (CLONTECH Laboratories, Inc.). Af-
ter correct orientation of the cDNA was confirmed, the stop codon of
PKC
 
a
 
 was mutated to an alanine codon by PCR-based mutagenesis (Cor-
mack, 1997), using the primers 5
 
9
 
-ATCCTTGTCCAAGGAGGCTGT-3
 
9
 
and 3
 
9
 
-TGGATCCACTGCACTCTGTAAGAT-5
 
9
 
 
 
to introduce the mu-
tation. Presence of the required alteration and absence of other PCR-
induced mutations was confirmed by sequencing. The PKC
 
a
 
-GFP fusion
cDNA was excised from this construct by consecutive digestion with Not1
and EcoR1. Between these digestions, the Not1 cut was blunt-ended using
the Klenow fragment of DNA polymerase. The cDNA was ligated into
the EcoR1 and blunt-ended BamH1 sites of pLXSN (CLONTECH Labo-
ratories, Inc.). This process generated the pLXSN-PKC
 
a
 
-GFP plasmid in
which expression of PKC
 
a
 
-GFP fusion protein is under control of the
Moloney murine leukemia virus long terminal repeat.
 
Transduction of IEC-18 Cells with PKC
 
a
 
-GFP
 
For packaging of retroviral particles, the Phoenix amphotropic cell line
(American Type Culture Collection) was transfected with pLXSN or
pLXSN-PKC
 
a
 
-GFP using the calcium phosphate precipitation method
(Chen and Okayama, 1987). Cells were exposed to precipitate for 12–18 h
in the presence of 25 
 
m
 
M chloroquine before fresh medium was applied
and cells were transferred to a 32
 
8
 
C incubator. After 24 h, medium contain-
ing retroviral particles was collected, cellular debris was removed by 0.45
 
m
 
M filtration, and retroviral supernatants were stored at 
 
2
 
70
 
8
 
C until use.
IEC-18 cells were plated at 5–6 
 
3 
 
10
 
5
 
/100-mm dish. After 24 h, medium
was removed and 3 ml of viral supernatants were applied in the presence of 7
ml complete medium and 4 
 
m
 
g/ml polybrene. Cells were exposed to retrovirus
for 24 h at 37
 
8
 
C, 5% CO
 
2
 
, and then subcultured in complete medium at a 1:4
ratio. Geneticin (G418; GIBCO BRL) was added at 2 mg/ml for 4 d to select
transduced cells. Cells expressing high levels of PKC
 
a
 
-GFP were collected by
fluorescence-activated cell sorting on the basis of GFP fluorescence. The
brightest 3% of cells were collected and expanded for use in experiments.
 
Flow Cytometric Analysis
 
Propidium iodide staining of cellular DNA was performed and quantified
as described previously (Frey et al., 1997). In brief, cells were fixed in 70%
ethanol and treated with 0.04 mg/ml RNase A (Sigma-Aldrich) in 20 mM
Tris, pH 7.5, 250 mM sucrose, 5 mM MgCl
 
2
 
, and 0.37% NP-40 (Sigma-
Aldrich). Cellular DNA was stained with 25 
 
m
 
g/ml propidium iodide
(Sigma-Aldrich) in 0.05% sodium citrate and quantified by flow cytome-
try. Cell cycle analysis was performed using the Winlist and Modfit pro-
grams (Verity Software House). Doublets were gated out based on pro-
pidium iodide fluorescence pulse-width, but all other events (including
any in the sub-2N region) were retained for analysis.
 
Rat Intestinal Epithelial Cell Isolation
 
Epithelial cells at different developmental stages were obtained by se-
quential release from rat intestine by timed incubations with EDTA-con-
taining buffer as described previously (Weiser, 1973; Saxon et al., 1994).
Upper villus (fraction 1), low-to-mid villus (fraction 5), and crypt cells
(fraction 9) were collected and washed twice with ice-cold PBS before fur-
ther processing. Crypt cells were obtained as pouches of short columnar
epithelium, consisting mainly (at least 60–70%) of proliferating (lower
crypt) cells (Bach et al., 2000), but including some differentiating (upper
crypt) cells. Isolated low-to-mid villus epithelium contained differentiat-
ing as well as some functionally mature cells, and upper villus fractions
contained only functionally mature cells. Each epithelial fraction was
characterized as described previously (Weiser, 1973; Burgess, 1989).
 
Preparation of Whole Cell Lysates
and Immunoprecipitates
 
For preparation of whole cell lysates, cell populations were solubilized in
boiling SDS lysis buffer (10 mM Tris, pH 7.4, 1% SDS). Extracts were
cleared by centrifugation (10 min, 10,000 
 
g
 
) and boiled in Laemmli sample
buffer (Laemmli, 1970) before being subjected to SDS-PAGE and West-
ern blot analysis. For immunoprecipitation experiments, subconfluent
IEC-18 cells were lysed in modified RIPA buffer (50 mM Tris, pH 7.5, 1
 
mM EGTA, 1 mM EDTA, 1% Triton X-100, 0.5 mM Na
 
3
 
VO
 
4
 
, 50 mM
NaF, 5 mM NaPPi, 10 mM 
 
b
 
-glycerophosphate, 0.1 mM PMSF, 1 
 
m
 
g/ml
leupeptin, and 1 
 
m
 
g/ml aprotinin). Lysates were cleared by centrifugation
and diluted 1:1 with PBS to reduce detergent concentration. Immunopre-
cipitations (500 
 
m
 
g cellular protein per reaction) were performed over-
night at 4
 
8
 
C with 2 
 
m
 
g anti–cyclin A, D, or E antibody followed by 60 min
with an excess of protein A/G agarose beads (Santa Cruz Biotechnology,
Inc.). Immune complexes were collected by centrifugation, washed five
times in modified RIPA buffer, and either boiled in Laemmli sample
buffer for Western blot analysis or used in kinase assays. 
 
Western Blot Analysis
 
SDS-PAGE and Western blot analysis were performed as described pre-
viously (Saxon et al., 1994; Frey et al., 1997), using either 10% (PKC
isozymes, pRb, p107, and p130) or 20% (cdks, cyclins, and CKIs) SDS-
polyacrylamide minigels. 30 
 
m
 
g of protein, assayed in quadruplicate by the
bicinchoninic acid (BCA) method (Pierce Chemical Co.), was loaded per
lane, and blots were routinely stained with either 0.1% Fast green (Sigma-
Aldrich) or 1% Amido black (Sigma-Aldrich) immediately after transfer
to ensure equal loading and even transfer. Primary antibody dilutions
were as follows: 1:500 for anti-Rb, –cyclin D1, and -p27
 
kip1
 
; 1:1,000 for
anti-p15, -p16, -p21
 
waf1/cip1
 
, -p107, -p130, -cdk2, -cdk4, -PKC
 
d
 
, -GFP, and
–cyclin A; and 1:2,000 for anti–cyclin E, –cyclin D (pan), -PKC
 
a
 
, and
-PKC
 
e
 
. Secondary antibodies were used at 1:2,000.
 
Immune Complex Kinase Assays
 
Immunoprecipitates were washed in RIPA buffer, resuspended in 40 
 
m
 
l
kinase assay buffer (25 mM Hepes, pH 7.4, 100 mM NaCl, 10 mM MgCl
 
2
 
,
5 mM MnCl
 
2
 
, 10% glycerol, 0.5 mM Na
 
3
 
VO
 
4
 
, 50 mM NaF, 5 mM NaPPi,
10 mM 
 
b
 
-glycerophosphate), combined with substrate (2 
 
m
 
g GST-pRb;
Santa Cruz Biotechnology, Inc.) or 10 
 
m
 
g purified histone H1 (Upstate
Biotechnology) and 10 
 
m
 
Ci [g-32P]ATP, and incubated for 20 min at 308C.
Reaction products were separated by SDS-PAGE and dried gels were ex-
posed to x-ray film. Autoradiograms were analyzed using a densitometer
and ImageQuant Software (Molecular Dynamics).
Selective Downregulation of PKCd and -e from
IEC-18 cells
Subconfluent IEC-18 cells were treated with 100 nM PMA for 15 min,
rinsed twice in DME, and returned to complete medium for 24 h. This
procedure has previously been demonstrated to selectively downregulate
PKCd and -e, producing a population of cells expressing PKCa as the ma-
jor agonist-responsive PKC isozyme (Frey et al., 1997). 
Results
Previous results from this laboratory have established a
strong link between PKC isozyme signaling and control of
cell growth/cell cycle progression in intestinal epithelial
cells. Several members of the PKC family (a, bII, d, and z)
undergo marked changes in expression and membrane as-
sociation, parameters indicative of PKC activation, pre-
cisely as cells cease division in the crypts of the small intes-
Table I. PKC Agonists Produce Cell Cycle Arrest in
IEC-18 Cells
Condition G0/G1 SG 2/M
Control 58 30 12
PMA 100 nM 69 8 23
dPP 100 nM 69 9 22
dPPA 200 nM 67 15 18
Thy 20 nM 68 10 22
Res 10 mM6 7 1 0 2 3
DiC8 58 mM6 5 1 5 2 0
Asynchronously growing IEC-18 cells were treated with PKC agonists for 6 h and
subjected to flow cytometric analysis to determine cell cycle distribution. PKC
activation resulted in a marked decrease in cells transiting through S phase.The Journal of Cell Biology, Volume 151, 2000 766
tine and colon in situ (Fig. 1, a–c) (Saxon et al., 1994;
Verstovsek et al., 1998). In addition, direct activation of
PKC (a, d, and e) in the IEC-18 intestinal crypt cell line
with a panel of PKC agonists, including phorbol esters
(PMA, dPP, PDBu, dPPA, Thy, and Res) and the diacyl-
glycerol analogue DiC8, results in cell cycle arrest in G0/G1
(Table I and Fig. 1 d) (Frey et al., 1997). Depletion of
Figure 1. Relationship be-
tween PKC signaling and
growth arrest in intestinal
epithelial cells. (a) Diagram
of intestinal epithelial crypt–
villus architecture, indicat-
ing the point of growth ar-
rest/PKC activation in the
midcrypt region and the
crypt–villus junction. (b) Im-
munodetection of BrdU in-
corporation to identify pro-
liferating cells in small
intestinal crypts. Arrow indi-
cates point of growth arrest.
P, proliferation zone; D, dif-
ferentiation zone; V, villus/
functional zone; J, crypt–vil-
lus junction. (c) Immuno-
fluorescence localization of
PKCa in rat duodenum.
PKCa is diffusely distributed
throughout the cytosol of
proliferating lower crypt
cells (P). Coincident with
growth arrest in the midcrypt
region (cell position 14–18
from the crypt base; arrow),
levels of PKCa markedly in-
crease and the protein be-
comes clearly detectable at
the cell periphery, in the
classical indication of PKC
activation. (d) IEC-18 cells
were treated with 100 nM
PMA for the indicated times
(U, control), and DNA con-
tent/cell cycle distribution
was determined by flow cyto-
metric analysis. PMA-induced
cell cycle arrest is held
for  z12 h of treatment. (e)
IEC-18 cells were treated
with 100 nM PMA for 12 h
and analyzed for expression
of PKC isozymes by Western
blot analysis. U, untreated.
(f) Vector control (Vec) and
PKCa-GFP–expressing IEC-
18 cells were treated with
100 nM PMA for the indi-
cated times, and cell cycle
distribution was determined by flow cytometric analysis. Although vector control cells reenter S phase by 12–14 h, PKCa-GFP–
expressing cells remain arrested until between 18 and 24 h. (g) Vector control and PKCa-GFP cells were treated with 100 nM PMA
for 12 h and subjected to Western blot analysis using antibodies against PKCa and GFP. Note that, although endogenous PKCa is un-
detectable in vector-transduced cells at 12 h, PKCa-GFP–transduced cells still contain readily detectable, albeit diminished, levels of
the fusion protein at this time point. Data are representative of at least four independent experiments (results of PKCa-GFP overex-
pression are representative of four separate transductions). Bar, 10 mm.
phorbol ester–responsive PKC isozymes (a, d, and e) by
long-term treatment with PDBu abrogates the growth-
inhibitory effects of these agents, pointing to PKC as a ma-
jor mediator of this response (Frey et al., 1997). Further-
more, the duration of the effect is directly related to the
presence of membrane-associated/active PKC in the cells.
Treatment of asynchronously growing IEC-18 cells withFrey et al. PKC-mediated Intestinal Epithelial Cell Cycle Exit 767
PMA, which initially activates but subsequently downreg-
ulates PKCa, -d, and -e in this system, results in a transient
cell cycle blockade (Fig. 1, d and e) (Frey et al., 1997).
Reversal of growth arrest at 12–14 h after addition of
PMA correlates with depletion of PMA-responsive PKC
isozymes, which occurs between 6 and 12 h of treatment
(Fig. 1 e) (Frey et al., 1997). In contrast, treatment with
agents such as DiC8 (Frey et al., 1997) and Res (Frey,
M.R., J.A. Clark, and J.D. Black, unpublished data),
which activate PKC isozymes in a sustained manner, re-
sults in sustained cell cycle arrest in these cells.
Previous studies using differential downmodulation of
individual PKC isozymes have pointed to PKCa as being
sufficient to mediate PMA-induced transient cell cycle
blockade (Frey et al., 1997). To confirm the involvement
of this isozyme in phorbol ester–induced cell cycle arrest,
IEC-18 cells were retrovirally transduced to express a
PKCa-GFP fusion protein, and effects of PMA on cell
cycle progression and PKC expression were examined.
Expression of PKCa-GFP significantly extended (z6 h
longer) phorbol ester–induced cell cycle arrest in this
system (Fig. 1 f), and this effect correlated with in-
creased (two- to threefold) and prolonged expression of
PKCa proteins in PKCa-GFP–transduced cells (Fig. 1
g). Expression of other PKC isozymes (d, e, z, and i) was
unaltered in PKCa-GFP–expressing cells, and phorbol
ester–induced downregulation of PKCd/e followed the
same kinetics as seen in vector control cells (data not
shown). Taken together with our previous findings, these
data directly support the involvement of member(s) of
the PKC family, and of PKCa in particular, in induction
and maintenance of cell growth/cell cycle arrest in intes-
tinal epithelial cells. 
To investigate further the mechanisms involved in
PKC-mediated inhibition of cell cycle progression in in-
testinal epithelial cells, PKC-induced alterations in the
expression and activity of critical cell cycle regulatory
molecules were determined in IEC-18 cells. The physio-
logical relevance of these changes was then evaluated
by comparing the developmental regulation of PKC
isozymes and cell cycle control molecules along the
crypt–villus axis in the unperturbed intestinal epithelium
in situ.
Figure 2. Altered expression
and phosphorylation of the
pocket proteins p107, pRb,
and p130 after PKC activa-
tion in IEC-18 cells. IEC-18
cells were treated with 100
nM PMA for the indicated
times (U, untreated), and expression and phosphorylation state of
pocket proteins were determined by Western blot analysis. Al-
tered phosphorylation of these molecules is reflected in character-
istic changes in their migration patterns on SDS gels. p130 is de-
tected as forms 1, 2, and 3; the accumulation of forms 1/2 after
PMA treatment is a hallmark of cell cycle withdrawal into G0.
Data are representative of at least three independent experiments.
Figure 3. Developmental regulation of
pocket protein expression and phosphoryla-
tion state in the intestinal epithelium in situ.
(a–c) Immunofluorescence localization of
pocket proteins. P, proliferation zone; D, dif-
ferentiation zone; V, villus/functional zone.
(a) p107 is readily detected in the nuclei of
proliferating lower crypt cells (P). Coincident
with growth arrest (arrow), p107 expression
decreases to barely detectable levels. (bi and
bii) pRb staining is evident in both nuclear
and cytosolic compartments of proliferating
crypt cells (P), and becomes predominantly
nuclear in postmitotic cells of the upper crypt
and villus (V). The arrow indicates the point
of growth arrest. (c) p130 staining is low in
proliferating crypt cells (P), but increases
markedly coincident with growth arrest (ar-
row). (d) Whole cell lysates (30 mg protein) of
isolated crypt (C), lower villus (LV), and up-
per villus (UV) cells were subjected to West-
ern blot analysis for expression and migra-
tion/phosphorylation state of pocket proteins.
Note that the crypt fraction includes some
postmitotic cells of the upper crypt region.
p130 form 3, which is only found in cycling
cells, is only detected in the crypt fraction; the
presence of forms 1 and 2 in this fraction re-
flects the postmitotic cells in this sample.
Data are representative of at least three inde-
pendent experiments. Bar, 10 mm.The Journal of Cell Biology, Volume 151, 2000 768
PKC Signaling Regulates Pocket Protein Expression 
and Phosphorylation State in Intestinal Epithelial Cells
To investigate the role of pocket proteins in PKC-medi-
ated cell cycle arrest in IEC-18 cells, the effects of PKC ac-
tivation on the expression and phosphorylation state of
these molecules were determined using Western blot anal-
ysis. This analysis was based on well-documented evidence
that alterations in phosphorylation state of pocket pro-
teins are reflected in characteristic changes in their migra-
tion patterns on SDS-PAGE gels (Ludlow et al., 1990; De-
Caprio et al., 1992; Whyte and Eisenman, 1992; Garriga et
al., 1998; Smith et al., 1998; Thomas et al., 1998). As shown
in Fig. 2, proliferating (untreated) IEC-18 cells express
p107, pRb, and small amounts of p130; p107 and pRb are
detected primarily in their hyperphosphorylated (i.e.,
slower-migrating), growth-permissive forms. Treatment
with 100 nM PMA resulted in decreased expression and
hypophosphorylation (i.e., appearance of characteristic
faster-migrating forms) of p107 and pRb, and a marked ac-
cumulation of the faster-migrating forms 1/2 of p130
(which is characteristic of cell cycle exit into G0; see Mayol
et al., 1995). These PMA-induced alterations were tran-
sient, reversing by 12–16 h after addition of agonist, coinci-
dent with release from cell cycle arrest as a consequence of
PKC downregulation (see Fig. 1, d and e).
To examine the physiological relevance of these data, a
combined biochemical and morphological approach (de-
scribed previously in Saxon et al., 1994) was used to com-
pare the developmental regulation of pocket protein ex-
pression, subcellular distribution, and phosphorylation
state along the crypt–villus axis in situ with changes in
PKC activation/expression. Immunofluorescence analysis
revealed that p107, pRb, and low levels of p130 are ex-
pressed in proliferating crypt cells (Fig. 3, a–c): p107 stain-
ing was predominantly nuclear, whereas pRb staining was
detected both in the cytoplasm and the nucleus. Coinci-
dent with cell growth arrest and PKC activation in the
midcrypt region (cell position 14–18 from the crypt base;
Fig. 1, b and c), all three pocket proteins underwent
changes in expression and/or subcellular compartmental-
ization. p107 became barely detectable in postmitotic cells,
whereas staining for pRb became restricted to the nucleus.
Levels of p130, on the other hand, increased markedly
with growth arrest and remained elevated on the villus, de-
creasing somewhat towards the villus tip. Consistent with
these immunofluorescence data, Western blot analysis of
pocket protein expression in isolated crypt, lower villus,
and upper villus cells demonstrated marked decreases in
levels of p107 and pRb in villus cells relative to crypt cells
(Fig. 3 d). Similar levels of p130 were detected in the crypt
and lower villus fractions, likely reflecting the presence of
postmitotic upper crypt cells in the crypt sample and of
some midvillus cells in the lower villus fraction (see Mate-
rials and Methods). Western blot analysis also demon-
strated that pRb and p130 are primarily expressed in their
underphosphorylated forms in postmitotic cells of the vil-
lus. Comparison of the data obtained from in vitro and in
situ studies (see Fig. 2 above) demonstrates that direct ac-
tivation of PKC isozymes in IEC-18 cells leads to alter-
ations in pocket protein expression and phosphorylation
state that closely parallel those seen coincident with PKC
activation within intestinal crypts in situ. Notably, the data
demonstrate that PKC activation in this system can initiate
a coordinated program of pocket protein regulation that
has been associated with cell cycle exit in several systems
(Garriga et al., 1998).
PKC Activation in IEC-18 Cells Results in Decreased 
Cdk Activity
To examine the mechanisms underlying PKC-induced al-
terations in pocket protein phosphorylation, cyclin D–, E–,
and A–cdk complexes were immunoprecipitated from
control and PMA-treated cells, and their activity was de-
termined in immune complex kinase assays (Fig. 4). Con-
sistent with findings in other intestinal epithelial model
systems (Tian and Quaroni, 1999), cyclin D–associated ki-
nase activity could not be detected in IEC-18 cells (data
not shown), possibly as a result of the low levels of cyclin
D expressed in these cells. On the other hand, kinase activ-
ity was readily detectable in cyclin E and cyclin A immu-
Figure 4. PKC activation inhibits cy-
clin E– and cyclin A–associated kinase
activity in IEC-18 cells. (a) Histone H1
kinase activity in cyclin E and cyclin A
immunoprecipitates was determined
by in vitro kinase assays and SDS-
PAGE autoradiography as described
in Materials and Methods. Results
shown are representative of three inde-
pendent assays. n/a, not applicable. (b)
Bar graphs depict average activity in
three replicate samples as determined
by densitometric analysis of autoradio-
grams. U, untreated.Frey et al. PKC-mediated Intestinal Epithelial Cell Cycle Exit 769
noprecipitates from untreated cells (Fig. 4), and the activ-
ity in both complexes was markedly inhibited after PMA
treatment. Cyclin E–associated activity was decreased by
46% at 2 h and by 73% at 6 h. By 8 h, although still inhib-
ited by 48%, cyclin E–cdk2 activity was beginning to re-
bound. Cyclin A–associated activity was decreased by 55%
within 2 h of treatment, and was below the accurate detec-
tion limit of the assay at 6 and 8 h (see Fig. 5).
Effects of PKC Activation on Cyclin–Cdk Expression 
Levels in Intestinal Epithelial Cells
Cdk activity can be affected by three major factors: ex-
pression of cdks and cyclins, positive and negative phos-
phorylation events, and association with CKIs (Chellap-
pan et al., 1998; Sherr and Roberts, 1999). To determine
whether changes in expression or phosphorylation of cdks
or cyclins could account for PKC-mediated inhibition of
cdk activity in IEC-18 cells, Western blot analysis of whole
cell lysates from control and PMA-treated IEC-18 cells
was performed. As shown in Fig. 5, no detectable changes
were observed in the expression or electrophoretic mobil-
ity (phosphorylation state) of cdks 4 and 2 in IEC-18 cells
over the course of PMA treatment. In contrast, alterations
in cyclin expression were observed after PKC activation in
IEC-18 cells. The most rapid changes were seen with the
D-type cyclins. As shown in Fig. 5, exposure to 100 nM
PMA consistently resulted in depletion of cyclin D/D1 by
Figure 5. Effect of PMA treatment on the expression of cyclins
and cdks in IEC-18 cells. Cells were exposed to 100 nM PMA for
the indicated times (U, untreated) and subjected to Western blot
analysis using antibodies specific for cdk4, cdk2, and cyclins D
(pan), D1, E, and A. Data are representative of three indepen-
dent experiments.
Figure 6. Analysis of the devel-
opmental regulation of cdk and
cyclin expression in the small in-
testinal epithelium. Immunoflu-
orescence analysis of (a) cdk4,
(b) cdk2, (c) cyclin E, and (d)
cyclin A expression was per-
formed on rat duodenal tissue.
All four molecules are readily
detectable in crypt cells (C), and
undergo a marked decrease in
expression at the crypt–villus
junction (J), well beyond the
point of growth arrest (arrow).
Note the variable expression of
cyclin A in proliferating cells (d,
inset). P, proliferation zone; D,
differentiation zone; V, villus.
(e) Western blot analysis of cdk
and cyclin expression in isolated
crypt (C), lower villus (LV), and
upper villus (UV) cell popula-
tions. Data are representative of
at least three independent ex-
periments. Bar, 10 mm.The Journal of Cell Biology, Volume 151, 2000 770
2 h of treatment. Expression of these molecules began to
rebound by 6 h and, interestingly, reached markedly
higher levels than those seen in untreated cells. Unlike the
D-type cyclins, cyclins E and A were both readily detect-
able in proliferating IEC-18 cells. Although cyclin E ex-
pression changed little with PKC activation, cyclin A lev-
els decreased markedly between 2 and 6 h of PMA
treatment, returning to control levels by 16 h (Fig. 5). No-
tably, the changes in cyclin A expression occurred well af-
ter the observed decreases in associated cdk activity (by
2 h; see Fig. 4). Thus, although the depletion of D cyclins
would be expected to result in loss of cdk4/6 activity, PKC-
induced inhibition of cyclin E– and A–associated kinase
activity (at early times) cannot be explained by decreased
expression of either cdk or cyclin subunits. 
Immunofluorescence analysis of cdk and cyclin expres-
sion in the intestinal epithelium in situ revealed additional
elements of the relationship between PKC signaling and
cell cycle regulation, and framed the data obtained in IEC-
18 cells in a physiological context. Although cyclin D/D1
was detected in proliferating crypt cells (data not shown),
the developmental control of D-type cyclins along the
crypt–villus axis could not be precisely discerned due to
the weak signal produced by pan-D and anti–cyclin D1 an-
tibodies in this tissue. Cdks 4 and 2 and cyclins E and A
were all detected in the nuclei of proliferating intestinal
crypt cells (Fig. 6, a–d). Levels of cyclin A expression var-
ied from cell to cell, presumably reflecting different stages
of the cell cycle (Fig. 6 d). Notably, major changes in the
expression of these cyclins and cdks were observed only at
the crypt–villus junction, well beyond the point of growth
arrest and PKC activation in the midcrypt region. As cells
exited the crypts, expression of cdks 4 and 2 and cyclins E
and A decreased markedly, although low levels of these
molecules remained detectable along the length of the vil-
lus. The regulation of cyclin and cdk expression in prolifer-
ating, differentiating, and functional intestinal epithelial
cells was confirmed by Western blot analysis of isolated
cell populations (Fig. 6 e). Together, these data suggest
that decreased expression of cdks 4 and 2 and cyclins E
and A in intestinal tissue is a downstream consequence
rather than a cause of the accumulation of cells in G0/G1,
and that the loss of cyclin E– and A–associated cdk activ-
ity observed shortly after PMA treatment of IEC-18 cells
is not due to limited cyclin or cdk availability.
PKC Signaling Regulates the Expression of Cip/Kip but 
Not Ink4 Family CKIs in Intestinal Epithelial Cells
Previous studies in this laboratory have demonstrated that
PKC agonist treatment of IEC-18 cells results in induction
of the Cip/Kip CKIs p21waf1/cip1 and p27kip1. This report ex-
tends these findings by (a) examining the extent and time
course of p21waf1/cip1 and p27kip1 induction, (b) determining
the association of p21waf1/cip1 and p27kip1 with cyclin–cdk
complexes, and (c) expanding the analysis to include the
Ink4 CKIs p15 and p16. As shown in Fig. 7 a, a substantial
accumulation of p21waf1/cip1 was observed in IEC-18 cells
by 2 h of PMA treatment, with levels remaining elevated
for 6 h and returning to baseline by 12 h. The increased ex-
pression of p27kip1 exhibited delayed kinetics relative to
p21waf1/cip1 induction, with peak levels sustained between 6
and 12 h of PMA treatment. (It should be noted that the
level of induction of p27kip1 exhibited some variability at
early time points, but was consistently high at later times.)
In contrast to the Cip/Kip CKIs, the Ink4 CKIs p15 and
p16 were not detected in either proliferating or PMA-
arrested IEC-18 cells. Thus, PKC-mediated intestinal epi-
thelial cell cycle arrest appears to involve specific induc-
tion of Cip/Kip CKIs, and does not require participation of
Ink4 family members (Fig. 7 a).
To determine if PKC activation in IEC-18 cells resulted
in increased association of Cip/Kip CKIs with cyclin–cdk
complexes, immunoprecipitates were prepared from con-
trol and PMA-treated cells using antibodies directed
against cyclin D, cyclin E, or cyclin A, and immunocom-
plexes were analyzed for the presence of p21waf1/cip1 and
p27kip1 by Western blotting. Markedly increased levels of
CKIs were detected in cyclin E and cyclin A immunocom-
plexes by 2 h (Fig. 7 b). CKI levels in cyclin E complexes
peaked at 6 h and began to decline by 8 h, whereas those
in cyclin A complexes decreased sharply by 6 h, paralleling
the loss of cyclin A expression at this time point (see Fig.
5). Increased association of p21waf1/cip1 and p27kip1 with cy-
clin D was not observed at early times after addition of
PMA, presumably reflecting the initial downregulation of
Figure 7. PKC activation in IEC-18 cells results in accumulation
of Cip/Kip, but not Ink4, CKIs in cyclin–cdk complexes. (a) IEC-
18 cells were exposed to 100 nM PMA for the indicated times (U,
untreated) and examined for CKI expression by Western blot
analysis (1, intestinal lower villus cell lysate as positive control).
(b) Cyclin–cdk complexes were immunoprecipitated (ip) from
control and PMA-treated IEC-18 cells using anti–cyclin D, E,
and A antibodies and analyzed for p21waf1/cip1 and p27kip1 expres-
sion by Western blotting. Data are representative of at least three
independent experiments.Frey et al. PKC-mediated Intestinal Epithelial Cell Cycle Exit 771
D-type cyclins resulting from this treatment (see Fig. 5).
However, significantly elevated levels of CKIs were seen
in cyclin D complexes at later times, paralleling the resur-
gence of cyclin D seen with PKC downregulation. Interest-
ingly, high levels of CKI recruitment to cyclin D immu-
nocomplexes at 8 h were coincident with decreased
association of p21waf1/cip1 and p27kip1 with cyclins E and A
and restoration of cyclin E–cdk2 activity. The sequestra-
tion of these CKIs by cyclin D–cdk4/6 complexes has been
suggested by some investigators to be a mechanism for re-
lief of cdk2 inhibition, contributing to orderly progression
through late G1 phase (Geng et al., 1999; Roberts, 1999).
Immunofluorescence analysis revealed that PKC-medi-
ated control of CKI expression in IEC-18 cells parallels
CKI regulation along the crypt–villus axis in situ. Rela-
tively low levels of p21waf1/cip1 were observed in the nuclei of
proliferating lower crypt cells, whereas p27kip1 was unde-
tectable in these cells (Fig. 8, a and b). Coincident with
growth arrest, upregulation/activation of PKC, and alter-
ations in pocket protein expression/phosphorylation, levels
of both Cip/Kip CKIs increased markedly. Upregulation of
p21waf1/cip1 was transient; expression remained high in the
actively differentiating cells of the upper crypt and lower
villus and decreased to barely detectable levels in func-
tional cells of the upper villus. p27kip1 expression, on the
other hand, remained relatively high in the entire postmi-
totic compartment. In contrast, changes in p15 and p16 ex-
pression did not correlate with growth arrest and PKC acti-
vation in the midcrypt region (Fig. 8, c and d). Moderate
levels of p15 and low amounts of p16 were detected in cells
throughout the entire crypt. Increased p15 expression be-
came apparent at the crypt–villus junction, which is well
into the postmitotic compartment (Fig. 8 c), and levels of
this molecule remained high along the length of the villus.
Figure 8. Developmental
regulation of CKI expres-
sion in the small intestinal
epithelium. (a–d) Immuno-
fluorescence localization of
CKIs in rat duodenum. (ai
and aii) Expression of
p21waf1/cip1 is weak in the nu-
clei of proliferating crypt
cells (P), increases markedly
coincident with growth arrest
(arrow in ai), and declines in
functional cells (F in aii) of
the villus. D, differentiation
zone. (b) p27kip1 staining is
undetectable in cells of the
lower crypt (P) and increases
markedly with growth ar-
rest, remaining high along
the length of the villus. (ci
and cii) p15 staining is
readily detectable in nuclei
of cells throughout the crypt
and increases at the crypt–
villus junction (J). V, villus;
arrow, point of growth arrest.
(di, dii) p16 staining is low in
crypt cells (C) and increases
gradually as cells migrate to-
wards the villus tip. In dii, ar-
row points to a villus cell nu-
cleus expressing p16. (e)
Whole cell lysates (30 mg
protein) of crypt (C), lower
villus (LV), and upper villus
(UV) populations were ex-
amined by Western blot
analysis for expression of
p21waf1/cip1, p27kip1, p15, and
p16. Note that the crypt frac-
tion includes some postmi-
totic cells of the upper crypt
region which account for the
p21waf1/cip1 and p27kip1 de-
tected in this sample. Data
are representative of at least
three independent experi-
ments. Bars, 10 mm.The Journal of Cell Biology, Volume 151, 2000 772
Levels of p16, on the other hand, increased gradually with
cell migration up the villus (Fig. 8 d). These patterns of Cip/
Kip and Ink4 family CKI regulation along the crypt–villus
unit were consistent with those observed by Western blot
analysis of isolated crypt, lower villus, and upper villus cells
(Fig. 8 e). Thus, upregulation of p21waf1/cip1 and p27kip1 ex-
pression in the midcrypt region coincides precisely with
changes in PKC expression/activation, alterations in pocket
protein expression/phosphorylation, and growth arrest.
Changes in p15 and p16 do not correlate with PKC activa-
tion in this system.
PKC Activation in IEC-18 Cells Results in 
Downregulation of the DNA Licensing Factor Cdc6
The depletion of D-type cyclins and coordinated alter-
ations in pocket protein expression/phosphorylation ob-
served after PMA treatment of IEC-18 cells suggested that
PKC activation in this system signals cell cycle withdrawal
into G0. To further investigate this possibility, control and
PMA-treated IEC-18 cells were analyzed for expression of
the cdc6 DNA licensing factor, a molecule that is strictly
associated with actively cycling populations and whose
downregulation is indicative of cell cycle exit (Stillman,
1996; Fujita, 1999). PKC activation in IEC-18 cells resulted
in marked downregulation of cdc6 by 2 h of treatment
(Fig. 9), confirming cell cycle withdrawal into G0 or a G0-
like state. Levels of this molecule recovered by 10–16 h,
reflecting downregulation of PKC isozymes and reentry of
IEC-18 cells into the cell cycle.
PKCa Is Sufficient to Initiate a Program of Cell Cycle 
Withdrawal in IEC-18 Cells
Work from this and other laboratories has linked PKCa,
in particular, to negative control of intestinal epithelial cell
growth (Frey et al., 1997; Abraham et al., 1998; Scaglione-
Sewell et al., 1998; also see Fig. 1). To investigate the abil-
ity of approximately physiological levels of this isozyme to
signal cell cycle exit in intestinal epithelial cells, a popula-
tion of IEC-18 cells expressing PKCa but not other phor-
bol ester–responsive isozymes was prepared by brief expo-
sure to PMA as described in Materials and Methods (Fig.
10 a) (Frey et al., 1997). We have previously shown that
activation of PKCa in this population by a second applica-
tion of PMA is sufficient to induce cell cycle arrest (Frey
et al., 1997). As shown in Fig. 10 b, retreatment of these
PKCa-expressing cells (P) with 100 nM PMA for 2 h (R)
resulted in hypophosphorylation and downregulation of
p107 and pRb, accumulation of forms 1/2 of p130, loss of
cyclin D, induction of p21waf1/cip1, and decreased expression
of cdc6. Thus, PKCa activation alone is sufficient to reca-
pitulate the conserved program of changes in CKIs, cy-
clins, and pocket proteins indicative of cell cycle with-
drawal into G0 or a G0-like state. The observed responses
were generally of slightly lesser magnitude than in control
cells expressing the full profile of PMA-responsive iso-
zymes, likely reflecting the slightly decreased amounts of
PKCa remaining after PMA pulse treatment (Fig. 10 a).
Although the participation of PKCd and -e in mediating
negative cell cycle regulation in these cells cannot be for-
mally excluded, their presence does not appear to be re-
quired to trigger a program of cell cycle exit in this system.
Discussion
Through coordinate analysis of in vitro and in situ model
systems, this study investigates the mechanisms by which
PKC regulates cell cycle progression in intestinal epithelial
cells. The data demonstrate for the first time that PKC ac-
tivation can initiate a specific program of molecular events
associated with cell cycle withdrawal into G0 or a G0-like
state. Treatment of IEC-18 intestinal crypt cells with PKC
agonists resulted in rapid downregulation of D-type cy-
clins, rapid and transient induction of p21waf1/cip1, delayed
but sustained accumulation of p27kip1, inhibition of cyclin
E– and cyclin A–associated kinase activity, coordinated al-
terations in pocket protein expression and phosphoryla-
tion, and downregulation of the DNA licensing factor
cdc6. Manipulation of PKC isozyme levels in IEC-18 cells
demonstrated that PKCa, in particular, is sufficient to pro-
duce this program of negative growth regulatory events.
Furthermore, comparison of the developmental regulation
of PKC isozymes and cell cycle control molecules in intes-
tinal epithelial tissue revealed that (a) the program of
events triggered by PKC activation in IEC-18 cells is repre-
sentative of the changes seen in cell cycle regulation coinci-
dent with growth arrest in situ, and (b) PKC activation is
appropriately positioned within intestinal crypts to initiate
this program of cell cycle exit–associated events in situ.
PKC Activation in Intestinal Epithelial Cells Results in 
Coordinated Changes in Pocket Protein Expression
and Phosphorylation
Data obtained from studies in multiple systems suggest a
model for control of cell cycle exit which involves both alter-
ations in pocket protein phosphorylation state and an or-
chestrated shift in relative levels of these molecules (Moberg
et al., 1996; Smith et al., 1996; Mayol and Graña, 1998). In
this model, proliferating cells primarily express p107 and
pRb as regulators of E2F function and thus G1/S progres-
sion; p130 is present at low levels in cycling cells. Cell cycle
exit and differentiation are associated with hypophosphory-
lation of p107 and pRb, disappearance of p107 (and, in some
systems, decreased expression of pRb), and marked accu-
mulation of phosphoforms 1 and 2 of p130. p130 forms 1/2
are maintained in G0 cells as long-term binding partners and
repressors of E2F-4. This program of pocket protein regula-
tion has been shown to occur during in vitro skeletal muscle
myogenesis (Garriga et al., 1998), granulocytic differentia-
tion of mouse myeloid precursor cells (Garriga et al., 1998),
and IFN-a–induced cell cycle exit of Daudi B cells (Thomas
et al., 1998). Furthermore, similar patterns of pocket protein
expression have been observed during epidermal differenti-
ation in situ (Paramio et al., 1998). 
Figure 9. PKC activation in
IEC-18 cells leads to loss of
cdc6 expression. Cells were
treated with 100 nM PMA for
the indicated times and sub-
jected to Western blot analysis
for cdc6 (U, untreated). Data
are representative of three in-
dependent experiments.Frey et al. PKC-mediated Intestinal Epithelial Cell Cycle Exit 773
Figure 10. PKCa activation is sufficient to initiate cell cycle withdrawal in
IEC-18 cells. (a) IEC-18 cells were pulsed with PMA for 15 min to selec-
tively downregulate PKCd and -e, and PKC isozyme expression was deter-
mined by Western blot analysis. (b) PKCd- and -e–depleted cells were re-
treated with PMA for 2 h and analyzed by Western blotting for expression
and migration/phosphorylation state of cell cycle regulatory molecules. U,
untreated; P, phorbol ester–pulsed cells expressing PKCa but not -d or -e;
R, PKCa-expressing cells retreated with PMA. Data are representative of
three independent experiments. (c) Model of PKCa-mediated intestinal
epithelial cell cycle withdrawal (see text for details). (d) Time line of events
involved in PKC-mediated cell cycle exit in IEC-18 cells.The Journal of Cell Biology, Volume 151, 2000 774
In striking parallel to these findings, the data presented in
the current study show that PKC-induced inhibition of cell
cycle progression in IEC-18 cells is associated with hypo-
phosphorylation and downregulation of p107 and pRb and
with coordinated upregulation of p130 forms 1/2 (see Fig.
2). Although previous work in other systems has linked
PKC to regulation of the function of pRb (for reviews see
Fishman et al., 1998; Black, 2000), the data presented here
are the first to implicate PKC signaling in coordinated regu-
lation of the expression and phosphorylation state of all
three members of the pocket protein family. The ability of
PKC signaling to induce this program of pocket protein
control in IEC-18 cells points to a role for member(s) of this
family in signaling cell cycle withdrawal in intestinal epithe-
lial cells. This notion is strengthened by the finding that
PKC activation within intestinal crypts in situ coincides pre-
cisely with similar changes in pocket protein regulation, i.e.,
decreased pocket protein phosphorylation, downregulation
of p107, decreased expression and restriction of pRb to the
nucleus, and increased expression of p130 (see Figs. 1 and
3). The disappearance of pRb from the cytoplasm of post-
mitotic cells (Fig. 3 b) (Chandrasekaran et al., 1996) sug-
gests an additional mechanism of pocket protein regulation;
however, the role of pocket protein subcellular distribution
in regulating E2F function remains to be determined. 
PKC Signaling Inhibits Cyclin–Cdk Activity in 
Intestinal Epithelial Cells
Inhibition of cyclin–cdk complex activity is critical for acti-
vation of pocket protein growth–suppressive function and
cell cycle exit (Graña and Reddy, 1995). PKC activation in
IEC-18 cells appears to negatively regulate the function of
all major cyclin–cdk complexes involved in G0/G1®S pro-
gression, i.e., cyclin D–cdk4/6, cyclin E–cdk2, and cyclin
A–cdk2. Regulation of cyclin–cdk complexes by PKC
signaling appears to involve two distinct mechanisms:
changes in cyclin expression (modulating cyclin D com-
plexes) and accumulation of CKIs (targeting cyclin E– and
cyclin A–associated activity).
PKC activation in IEC-18 cells resulted in rapid disap-
pearance of D-type cyclins, presumably leading to loss of
any cdk4/6 activity present in these cells. Although de-
layed expression of cyclin D has been observed after
growth factor stimulation of quiescent PKC-overexpress-
ing cells in other systems (Fukumoto et al., 1997; Ashton
et al., 1999), to our knowledge this study is the first to
demonstrate the ability of PKC signaling to mediate the
downregulation of this molecule in actively cycling cells.
Several lines of evidence exclude a role for CKI accumula-
tion in PKC-mediated modulation of cyclin D–associated
activity. First, PKC has not been linked to induction of the
cyclin D–cdk4/6-specific CKIs p15 or p16 in any system
(Black, 2000), including IEC-18 cells (see Fig. 7 a), and
PKC activation in intestinal crypts in situ does not coin-
cide with increased expression of either of these CKIs (see
Fig. 8). Furthermore, recent evidence suggests that the
Cip/Kip CKIs p21waf1/cip1 and p27kip1 are inefficient inhibi-
tors of cyclin D–associated cdk activity (LaBaer et al.,
1997), a notion supported by a study of Caco-2 colon ade-
nocarcinoma cell differentiation in which association with
p21waf1/cip1 was shown to be a critical component of cdk2
but not cdk4 inhibition (Ding et al., 1998). Together these
data support a role for downregulation of D-type cyclins,
rather than CKI association, in regulation of cdk4/6 activ-
ity by PKC-mediated signaling. Since levels of cyclin D re-
main relatively constant throughout the cell cycle in cy-
cling cells and destruction of this molecule has been shown
to be an early event in cell cycle withdrawal into G0
(Zwijsen et al., 1996), these data provide additional evi-
dence for the ability of PKC signaling to induce a G0-like
state in this system. The resurgence of cyclin D in IEC-18
cells after downregulation of PKC isozymes likely reflects
reversal of cell cycle withdrawal and reentry of these cells
from G0 into G1; similar hyperinduction of this molecule
has been reported during serum-stimulated cell cycle entry
from quiescence in several systems (e.g., Coppock et al.,
1995; Fukumoto et al., 1997).
Inhibition of cdk2 complexes by PKC activation in IEC-
18 cells appears to be accomplished through CKI binding
rather than by destruction of cyclins. In this regard, cyclin
E and cyclin A levels remained unchanged at times when
their associated cdk activity was significantly inhibited
(see Figs. 4 and 5). Downregulation of cyclin A was only
observed at later time points (6 and 12 h), likely as a con-
sequence of PKC-induced accumulation of cells in G0/G1
(cell cycle stages at which cyclin A is not normally ex-
pressed; Graña and Reddy, 1995). These findings are con-
sistent with data from other systems demonstrating PKC-
induced inhibition of cdk2 activity under conditions in
which levels of cyclins E or A were not limiting (Coppock
et al., 1995; Livneh et al., 1996; Ashton et al., 1999). The
notion that intestinal epithelial cell cycle withdrawal does
not require the destruction of cyclins E and/or A was con-
firmed by the observation that, in intestinal tissue, down-
regulation of these molecules occurs at the crypt–villus
junction, well after growth arrest in the midcrypt region
(see Fig. 6). Although PKC activation in IEC-18 cells did
not result in early alterations in cyclin E or A expression,
increased levels of Cip/Kip CKIs were detected in both cy-
clin E and A complexes soon after PMA treatment, and
could thus account for the observed inhibition of their as-
sociated kinase activity. The finding that p21waf1/cip1 and
p27kip1 induction in the midcrypt region in situ coincides
precisely with PKC activation (see Figs. 8 and 1 a) is con-
sistent with this idea. A link between PKC signaling and
increased Cip/Kip CKI expression has also been observed
in a variety of other systems, including various epithelial
cell types, leukemic cells, and cell lines overexpressing
specific PKC isozymes (for review see Black, 2000). To-
gether with the absence of evidence for direct effects of
PKC activation on cyclin or cdk expression or phosphory-
lation, these data suggest that increased association with
Cip/Kip CKIs is the major mechanism for inhibition of cy-
clin E– and cyclin A–associated cdk activity by PKC sig-
naling in intestinal epithelial cells.
PKC Signaling Differentially Regulates Cip/Kip CKI 
Expression in Intestinal Epithelial Cells
Although PKC signaling resulted in increased expression
of both p21waf1/cip1 and p27kip1 in IEC-18 cells, marked dif-
ferences were observed in the kinetics of induction of
these molecules. Levels of p21waf1/cip1 peaked early after
PMA treatment and rapidly returned to those seen in con-
trol cells. In contrast, induction of p27kip1 peaked later and
increased levels were sustained as long as the cells re-
mained in G0. Consistent with these results, PKC-medi-Frey et al. PKC-mediated Intestinal Epithelial Cell Cycle Exit 775
ated transient induction of p21waf1/cip1 has been noted in
venous endothelial cells (Zezula et al., 1997), leukemic cell
lines (Asiedu et al., 1995), and keratinocytes (Todd and
Reynolds, 1998), and sustained induction of p27kip1 has
been observed during PMA-induced hematopoietic differ-
entiation (Asiedu et al., 1997). Notably, these findings par-
allel the developmental regulation of Cip/Kip CKIs along
the crypt–villus axis in situ. Although p21waf1/cip1 and
p27kip1 are both upregulated coincident with growth arrest
within intestinal crypts, elevated levels of p21waf1/cip1 are
present only during early stages of differentiation (Fig. 8)
(Gartel et al., 1996), whereas p27kip1 expression is sus-
tained along the length of the villus. Similarly, increased
p21waf1/cip1 expression was detected only during early
stages of maturation of conditionally immortalized human
fetal intestinal cells in vitro, whereas p27kip1 induction was
delayed and sustained, coinciding with the appearance of
morphological and functional markers of differentiation
(Tian and Quaroni, 1999). Recent findings suggest that the
differential kinetics of induction of Cip/Kip CKIs reflect
distinct roles for these molecules in the differentiation
process, with p21waf1/cip1 playing a part in initiating irre-
versible growth arrest and p27kip1 functioning later to in-
duce or maintain tissue-specific gene expression (Tian and
Quaroni, 1999; Yamamoto et al., 1999). Evidence that
p21waf1/cip1 expression may in fact play an inhibitory role
during late stages of differentiation (Di Cunto et al., 1998;
Yamamoto et al., 1999) suggests that its downregulation is
required for completion of the maturation process. Taken
together, these findings demonstrate that PKC signaling
can regulate Cip/Kip family CKI expression in a manner
consistent with that seen in association with cell cycle exit
and differentiation in a variety of biological systems. 
PKCa Signals Cell Cycle Exit in Intestinal
Epithelial Cells
To determine the specific PKC isozyme(s) involved in sig-
naling cell cycle exit in intestinal epithelial cells, we took
advantage of our previous finding that brief exposure to
PMA, followed by extended incubation in the absence of
drug, generates a population of IEC-18 cells expressing
PKCa but not other phorbol ester–responsive isozymes
(Frey et al., 1997). Activation of PKCa in these cells pro-
duced the same program of cell cycle exit–associated
events observed after PKC agonist treatment of IEC-18
cells expressing the full panel of PKC isozymes. These
data are consistent with the ability of PKCa to mediate
cell cycle arrest and differentiation in a variety of in vitro
systems (Gruber et al., 1992; Mischak et al., 1993; Murray
et al., 1993; Abraham et al., 1998; Scaglione-Sewell et al.,
1998; Desai et al., 1999; Slosberg et al., 1999), with the
demonstration that PKCa overexpression can potentiate
phorbol ester–mediated growth arrest in mammary (Slos-
berg et al., 1999) and intestinal epithelial cells (see Fig. 1),
and with the observation that activation of this isozyme is
maintained in all postmitotic cells of the intestinal epithe-
lium in situ (Saxon et al., 1994) (see Fig. 1 a). These find-
ings strongly support the involvement of PKCa, in particu-
lar, in mediating a program of cell cycle withdrawal,
although it remains to be determined whether other mem-
bers of the PKC family play a role in this process. For ex-
ample, it is possible that downregulation of PKCe, which
has been implicated in positive regulation of cell growth
(e.g., Cacace et al., 1993), is also required for execution of
this program. The continued proliferation of cells depleted
of PKCa, -d, and -e, however, indicates that PKCe down-
regulation in the absence of active PKCa is not sufficient
to produce growth arrest of these cells. 
In summary, the data presented herein indicate that PKC
signaling plays an important role in initiating a coordinated
program of cell cycle exit in intestinal epithelial cells and
suggest a model of PKC-mediated cell cycle exit (summa-
rized in Fig. 10, c and d). In this model, PKCa activation in
IEC-18 cells leads to inhibition of G1/S cyclin–cdk activity
via two distinct mechanisms: downregulation of D-type cy-
clins, which inhibits cdk4/6 activity, and accumulation of
p21waf1/cip1 and p27kip1, which leads to inhibition of cyclin E–
and cyclin A–associated cdk2. These effects result in hypo-
phosphorylation/downregulation of p107 and pRb and ac-
cumulation of p130 forms 1/2, events which drive cells to
exit the cell cycle into G0, as indicated by concomitant
downregulation of cdc6. Sustained expression of p27kip1
and upregulation of p130 suggest that PKC-mediated cell
cycle withdrawal is linked to the onset of a differentiation
program. Analysis of the developmental regulation of
pocket proteins, cyclins, cdks, and CKIs in intestinal epi-
thelial tissue demonstrates that the program of cell cycle–
specific events resulting from PKC activation in cultured
cells closely parallels the changes seen coincident with PKC
activation/growth arrest in the midcrypt region in situ. We
also propose that sustained activation of PKC is required
for maintenance of cell cycle exit in this system. As PKCa
is downregulated from phorbol ester–treated IEC-18 cells,
cyclin D is reexpressed and accumulates to high levels (see
Fig. 5), sequestering Cip/Kip CKIs (see Fig. 7) to promote
assembly of cyclin D–cdk4/6 complexes (Roberts, 1999).
Sequestration of p21waf1/cip1 and p27kip1 in cyclin D com-
plexes, combined with decreased expression of p21waf1/cip1
(see Fig. 7), relieves inhibition of cdk2 (Roberts, 1999) (see
Fig. 4), allowing inactivation of pocket proteins and pro-
gression through the cell cycle.
The physiological importance of PKC-mediated nega-
tive control of cell cycle progression is underscored by evi-
dence of decreased PKC expression or activity in colonic
tumors (Guillem et al., 1987; Wali et al., 1991; Kahl-Rainer
et al., 1996; Verstovsek et al., 1998), by the ability of phor-
bol ester treatment to inhibit growth in normal colonic tis-
sue from biopsies (Assert et al., 1999), and by evidence
that certain PKC isozymes can act as tumor suppressors in
intestinal epithelial cells (Choi et al., 1990; Abraham et al.,
1998; Scaglione-Sewell et al., 1998). Since PKC activation
and/or overexpression have been shown to inhibit cell
growth/cell cycle progression in a variety of systems, the
results presented in this study may represent a conserved
growth-inhibitory function for one or more members of
the PKC family.
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